Axis III disorders in treatment-resistant major depressive disorder. (Q53927460)

22 May 2018

title

Axis III disorders in treatment-resistant major depressive disorder. (English)

1 reference

22 May 2018

author

Jonathan E. Alpert

5

1 reference

22 May 2018

author name string

George I Papakostas

1

1 reference

22 May 2018

Timothy Petersen

2

1 reference

22 May 2018

Dan V Iosifescu

3

1 reference

22 May 2018

Pamela A Roffi

4

1 reference

22 May 2018

Jerrold F Rosenbaum

6

1 reference

22 May 2018

Maurizio Fava

7

1 reference

22 May 2018

Andrew A Nierenberg

8

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

22 May 2018

published in

Psychiatry Research

1 reference

22 May 2018

volume

118

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

183-188

1 reference

22 May 2018

Executive dysfunction and long-term outcomes of geriatric depression.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Outcome of anxiety and depression at two and a half years after baseline interview: associations with changes in psychiatric morbidity among three samples of elderly people living at home

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Treatment of depression in the elderly: effect of physical illness on response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

An open-label trial of citalopram for major depression in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Physical illness manifesting as psychiatric disease. II. Analysis of a state hospital inpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Depression and physical illness among elderly general medical clinic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Depressive symptoms, medical illness, and functional status in depressed psychiatric inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Nortriptyline for treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Lithium Augmentation of Nortriptyline for Subjects Resistant to Multiple Antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

The outcome of antidepressant use in the medically ill

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900067-2

7 January 2021

10.1016/S0165-1781(03)00067-2

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018